Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Confirmatory Evidence Used in Non-Oncologic Rare Disease New Molecular Entity Marketing Applications Approved by FDA, 2020-2023.
Journal: Clinical pharmacology and therapeutics
Published: December 10, 2024
Pioglitazone and bladder cancer: FDA's assessment.
Journal: Pharmacoepidemiology and drug safety
Published: September 27, 2016
Impact of study design on the evaluation of inhaled and intranasal corticosteroids' effect on hypothalamic-pituitary-adrenal axis function.
Journal: Journal of pharmaceutical sciences
Published: May 20, 2014
Impact of study design on the evaluation of inhaled and intranasal corticosteroids' effect on hypothalamic-pituitary-adrenal axis function, part I: general overview of HPA axis study design.
Journal: Journal of pharmaceutical sciences
Published: March 28, 2013
Showing 1-4 of 4
Last Updated: 09/26/2026